Delphine Le Louet
Stock Analyst at Bernstein
(0.37)
# 4,043
Out of 4,334 analysts
174
Total ratings
42%
Success rate
-6.9%
Average return
Main Sectors:
Stocks Rated by Delphine Le Louet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €284.00 | $233.00 | +21.89% | 20 | Apr 23, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Maintained: Hold | €27.90 | $23.84 | +17.03% | 2 | Mar 31, 2026 | |
| ETR: GXI Gerresheimer AG | Maintained: Sell | €31.50 → €18.90 | $27.38 | -30.97% | 13 | Feb 12, 2026 | |
| SWX: TECN Tecan Group AG | Upgraded: Hold | CHF 165.20 → CHF 156.00 | $149.10 | +4.63% | 2 | Jan 16, 2026 | |
| STO: GETI.B Getinge AB (publ) | Initiated Coverage: Hold | kr 228.00 | $192.65 | +18.35% | 1 | Jun 17, 2025 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Hold | €172.00 → €234.00 | $171.70 | n/a | 14 | Apr 16, 2025 | |
| EPA: ERF Eurofins Scientific SE | Maintained: Hold | €52.80 → €53.80 | $61.96 | n/a | 7 | Nov 28, 2024 | |
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | €5.70 → €3.03 | $3.22 | n/a | 10 | Mar 17, 2024 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | CHF 77.60 → CHF 72.20 | $53.02 | n/a | 16 | Feb 29, 2024 | |
| EPA: IPN Ipsen S.A. | Maintained: Buy | €142.00 → €150.40 | $161.40 | n/a | 14 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 → €13.60 | $4.55 | n/a | 9 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €57.00 → €57.10 | $34.62 | n/a | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €20.10 → €18.95 | $23.18 | n/a | 12 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €186.40 → €189.80 | $172.10 | n/a | 19 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €103.00 → €101.00 | $71.90 | n/a | 15 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.94 | n/a | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €579.00 → €612.00 | $182.60 | n/a | 6 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $13 | $18.16 | n/a | 4 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $148 | $100.34 | n/a | 1 | Oct 8, 2020 |
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €284.00
Current: $233.00
Upside: +21.89%
Lakefront Biotherapeutics NV
Mar 31, 2026
Maintained: Hold
Price Target: €27.90
Current: $23.84
Upside: +17.03%
Gerresheimer AG
Feb 12, 2026
Maintained: Sell
Price Target: €31.50 → €18.90
Current: $27.38
Upside: -30.97%
Tecan Group AG
Jan 16, 2026
Upgraded: Hold
Price Target: CHF 165.20 → CHF 156.00
Current: $149.10
Upside: +4.63%
Getinge AB (publ)
Jun 17, 2025
Initiated Coverage: Hold
Price Target: kr 228.00
Current: $192.65
Upside: +18.35%
Sartorius Stedim Biotech S.A.
Apr 16, 2025
Maintained: Hold
Price Target: €172.00 → €234.00
Current: $171.70
Upside: n/a
Eurofins Scientific SE
Nov 28, 2024
Maintained: Hold
Price Target: €52.80 → €53.80
Current: $61.96
Upside: n/a
DBV Technologies S.A.
Mar 17, 2024
Maintained: Buy
Price Target: €5.70 → €3.03
Current: $3.22
Upside: n/a
Alcon Inc.
Feb 29, 2024
Maintained: Hold
Price Target: CHF 77.60 → CHF 72.20
Current: $53.02
Upside: n/a
Ipsen S.A.
Jan 3, 2024
Maintained: Buy
Price Target: €142.00 → €150.40
Current: $161.40
Upside: n/a
Dec 22, 2023
Maintained: Buy
Price Target: €20.30 → €13.60
Current: $4.55
Upside: n/a
Nov 13, 2023
Maintained: Buy
Price Target: €57.00 → €57.10
Current: $34.62
Upside: n/a
Oct 24, 2023
Maintained: Hold
Price Target: €20.10 → €18.95
Current: $23.18
Upside: n/a
Oct 20, 2023
Upgraded: Buy
Price Target: €186.40 → €189.80
Current: $172.10
Upside: n/a
Sep 29, 2023
Maintained: Hold
Price Target: €103.00 → €101.00
Current: $71.90
Upside: n/a
Oct 13, 2022
Downgraded: Hold
Price Target: n/a
Current: $26.94
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: €579.00 → €612.00
Current: $182.60
Upside: n/a
May 4, 2021
Upgraded: Hold
Price Target: $13
Current: $18.16
Upside: n/a
Oct 8, 2020
Upgraded: Hold
Price Target: $148
Current: $100.34
Upside: n/a